1 BTC
=
- USD
Astria Therapeutics, Inc. Common Stock
As of May 30, 2026 at 24:05 UTC
Chart
About Astria Therapeutics, Inc. Common Stock
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
Market Statistics
Trading Metrics
How to Buy ATXS
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy ATXS
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesInvestor rights law firm Halper Sadeh LLC is investigating three companies for potential federal securities law violations and breaches of fiduciary duties related to their merger transactions: Astria Therapeutics' sale to BioCryst Pharmaceuticals, Green Dot Corporation's sale to Smith Ventures and CommerceOne Financial Corporation, and United Security Bancshares' sale to Community West Bancshares. The firm is seeking increased consideration for shareholders and additional disclosures on a contingent fee basis.
